Bart Spiessens

Beerse, VLG 2340, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Correction: Leroux-Roels et al. Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. Vaccines 2026, 14, 146.

Correction: Leroux-Roels et al. Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. Vaccines 2026, 14, 146.

Journal: Vaccines

Published: May 06, 2026

Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.

Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.

Journal: Vaccines

Published: December 22, 2025

A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.

A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.

Journal: Epidemiology and infection

Published: September 03, 2025

Adopting the estimand framework in prophylactic vaccine trials.

Adopting the estimand framework in prophylactic vaccine trials.

Journal: Vaccine

Published: July 11, 2025

Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017.

Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017.

Journal: Epidemiology and infection

Published: January 06, 2025

Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60-85 years in a randomized, double-blind, phase 1 study.

Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60-85 years in a randomized, double-blind, phase 1 study.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: June 04, 2024

A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease.

A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease.

Journal: The Journal of antimicrobial chemotherapy

Published: February 05, 2024

Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning.

Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning.

Journal: BMC infectious diseases

Published: November 07, 2023

A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.

A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.

Journal: NPJ vaccines

Published: October 23, 2023

Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials.

Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials.

Journal: Expert review of vaccines

Published: September 26, 2023

Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.

Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.

Journal: Infection

Published: August 16, 2023

Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.

Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: April 19, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026